Evaluation of carbenoxolone sodium in the treatment of duodenal ulcer
View abstract on PubMed
Summary
This summary is machine-generated.Carbenoxolone sodium capsules significantly improved duodenal ulcer healing compared to placebo over six weeks. While symptom relief varied, endoscopic results confirmed carbenoxolone
Area Of Science
- Gastroenterology
- Pharmacology
Background
- Duodenal ulcers are a common gastrointestinal condition.
- Effective treatments are crucial for patient outcomes.
Purpose Of The Study
- To evaluate the efficacy of carbenoxolone sodium positioned-release capsules in treating duodenal ulcers.
- To compare carbenoxolone treatment with placebo under endoscopic control.
Main Methods
- A double-blind, placebo-controlled trial.
- Involved 44 patients (21 carbenoxolone, 23 placebo) over 6 weeks.
- Endoscopic assessment of ulcer healing.
Main Results
- Complete ulcer healing observed in 14/21 (66.7%) carbenoxolone patients vs. 7/23 (30.4%) placebo patients.
- The difference in healing rates was statistically significant (P < 0.016).
- Symptom relief showed poor correlation with endoscopic ulcer healing.
Conclusions
- Carbenoxolone sodium positioned-release capsules demonstrate significant therapeutic efficacy for duodenal ulcers.
- Potential side effects (weight gain, hypertension, hypokalemia) are manageable with monitoring.
- Confirms carbenoxolone as a viable treatment option for duodenal ulcers.